1239 related articles for article (PubMed ID: 8971556)
1. Expression of metastasis suppressor gene product, nm23 protein, is not inversely correlated with the tumour progression in human malignant melanomas.
Saitoh K; Takahashi H; Yamamoto M; Kishi H; Parsons PG
Histopathology; 1996 Dec; 29(6):497-505. PubMed ID: 8971556
[TBL] [Abstract][Full Text] [Related]
2. An immunohistochemical analysis of nm23 gene product expression in uveal melanoma.
Greco IM; Calvisi G; Ventura L; Cerrito F
Melanoma Res; 1997 Jun; 7(3):231-6. PubMed ID: 9195562
[TBL] [Abstract][Full Text] [Related]
3. Expression of NM23 in human melanoma progression and metastasis.
Easty DJ; Maung K; Lascu I; Véron M; Fallowfield ME; Hart IR; Bennett DC
Br J Cancer; 1996 Jul; 74(1):109-14. PubMed ID: 8679442
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of nm23 protein expression in malignant melanoma. An immunohistochemical study.
van den Oord JJ; Maes A; Stas M; Nuyts J; De Wever I; De Wolf-Peeters C
Melanoma Res; 1997 Apr; 7(2):121-8. PubMed ID: 9167178
[TBL] [Abstract][Full Text] [Related]
5. Expression of NM23 protein in acquired melanocytic nevi, malignant melanoma and metastases of malignant melanoma: an immunohistological assessment in human skin.
Reichrath J; Seyfried P; Braun R; Müller SM; Baum HP; Bahmer FA
Dermatology; 1997; 194(2):136-9. PubMed ID: 9094461
[TBL] [Abstract][Full Text] [Related]
6. The role of nm23 in melanoma progression and its prognostic significance.
Betke H; Korabiowska M; Brinck U; Trybus-Gałuszka H; Kellner S; Okoń K; Stachura J; Droese M
Pol J Pathol; 1998; 49(2):93-6. PubMed ID: 9798412
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical demonstration of the nm23-H1 gene product in human malignant melanoma and Spitz nevi.
Lee CS; Pirdas A; Lee MW
Pathology; 1996 Aug; 28(3):220-4. PubMed ID: 8912348
[TBL] [Abstract][Full Text] [Related]
8. Nm23/nucleoside diphosphate (NDP) kinase expression in human malignant melanomas: significance and implications in tumor biology.
Bodey B; Bodey B; Gröger AM; Siegel SE; Kaiser HE
Anticancer Res; 1997; 17(1A):505-11. PubMed ID: 9066703
[TBL] [Abstract][Full Text] [Related]
9. A low NM23.H1 gene expression identifying high malignancy human melanomas.
Caligo MA; Grammatico P; Cipollini G; Varesco L; Del Porto G; Bevilacqua G
Melanoma Res; 1994 Jun; 4(3):179-84. PubMed ID: 7919963
[TBL] [Abstract][Full Text] [Related]
10. NM23 expression in metastasis of malignant melanoma is a predictive prognostic parameter correlated with survival.
Xerri L; Grob JJ; Battyani Z; Gouvernet J; Hassoun J; Bonerandi JJ
Br J Cancer; 1994 Dec; 70(6):1224-8. PubMed ID: 7981081
[TBL] [Abstract][Full Text] [Related]
11. Expression of the nm23 metastasis-suppressor gene product in skin tumors.
Kanitakis J; Euvrard S; Bourchany D; Faure M; Claudy A
J Cutan Pathol; 1997 Mar; 24(3):151-6. PubMed ID: 9085150
[TBL] [Abstract][Full Text] [Related]
12. NM23-H1 immunostaining is inversely associated with tumour staging but not overall survival or disease recurrence in colorectal carcinomas.
Cheah PY; Cao X; Eu KW; Seow-Choen F
Br J Cancer; 1998 Apr; 77(7):1164-8. PubMed ID: 9569056
[TBL] [Abstract][Full Text] [Related]
13. Inverse association of nm23-H1 expression by colorectal cancer with liver metastasis.
Yamaguchi A; Urano T; Fushida S; Furukawa K; Nishimura G; Yonemura Y; Miyazaki I; Nakagawara G; Shiku H
Br J Cancer; 1993 Nov; 68(5):1020-4. PubMed ID: 8217591
[TBL] [Abstract][Full Text] [Related]
14. P53 is a regulator of the metastasis suppressor gene Nm23-H1.
Chen SL; Wu YS; Shieh HY; Yen CC; Shen JJ; Lin KH
Mol Carcinog; 2003 Apr; 36(4):204-14. PubMed ID: 12669312
[TBL] [Abstract][Full Text] [Related]
15. nm23--relationship to the metastatic potential of breast carcinoma cell lines, primary human xenografts, and lymph node negative breast carcinoma patients.
Russell RL; Geisinger KR; Mehta RR; White WL; Shelton B; Kute TE
Cancer; 1997 Mar; 79(6):1158-65. PubMed ID: 9070493
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of nm23 H-1 protein in conjunctival melanoma and potential precursor lesions.
Seregard S; Oskarsson M; Spângberg B
Exp Eye Res; 1999 Dec; 69(6):671-6. PubMed ID: 10620396
[TBL] [Abstract][Full Text] [Related]
17. Expression of a catalytically inactive H118Y mutant of nm23-H2 suppresses the metastatic potential of line IV Cl 1 human melanoma cells.
Hamby CV; Abbi R; Prasad N; Stauffer C; Thomson J; Mendola CE; Sidorov V; Backer JM
Int J Cancer; 2000 Nov; 88(4):547-53. PubMed ID: 11058869
[TBL] [Abstract][Full Text] [Related]
18. nm23 Protein expression in larynx cancer and the relationship with metastasis.
Gunduz M; Ayhan A; Gullu I; Onerci M; Hosal AS; Gursel B; Hosal IN; Firat D
Eur J Cancer; 1997 Dec; 33(14):2338-41. PubMed ID: 9616278
[TBL] [Abstract][Full Text] [Related]
19. Observations on tumor and metastatic suppressor gene status in endometrial carcinoma with particular emphasis on p53.
Ambros RA; Vigna PA; Figge J; Kallakury BV; Mastrangelo A; Eastman AY; Malfetano J; Figge HL; Ross JS
Cancer; 1994 Mar; 73(6):1686-92. PubMed ID: 8156496
[TBL] [Abstract][Full Text] [Related]
20. Expression of p53 and NDP-K/nm23 in gastric carcinomas--association with metastasis and clinicopathologic parameters.
Kim KM; Lee A; Chae HS; Shim SI
J Korean Med Sci; 1995 Dec; 10(6):406-13. PubMed ID: 8924224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
